Related Experiment Video

Updated: Jun 27, 2026

Laboratory Estimation of Net Trophic Transfer Efficiencies of PCB Congeners to Lake Trout (Salvelinus namaycush) from Its Prey
12:24

Laboratory Estimation of Net Trophic Transfer Efficiencies of PCB Congeners to Lake Trout (Salvelinus namaycush) from Its Prey

Published on: August 29, 2014

[Levels of polychlorinated biphenyls in human milk in dependent on selected factors]

Renata Pietrzak-Fiećko1, Stefan S Smoczyński, Zbigniew Borejszo

  • 1Katedra Fizyki i Biofizyki, Uniwersytet Warmińsko-Mazurski w Olsztynie, 10-719 Olsztyn, ul. Oczapowskiego 4.

Roczniki Panstwowego Zakladu Higieny
|December 23, 2008
PubMed

The contents of polychlorinated biphenyls in human milk were determined. The PCB levels in human milk were determined in relation to factors such as: age and weight of women, birthweight of the baby, smoking, period of breast-feeding (3-5 days, 2-4 weeks, 6-8 month) and seasons of the year. It was found that level of PCB in human milk have been decreasing during lactation. PCB levels in human milk decreases with increasing weight of women. The level of PCB in human milk increases together with age of women. The higher PCB levels were determined in human milk from women smoking cigarettes.

More Related Videos

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

A Method for Targeted 16S Sequencing of Human Milk Samples09:09

A Method for Targeted 16S Sequencing of Human Milk Samples

Published on: March 23, 2018

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...